VitaDAO (VITA)

Governance and Funding

VitaDAO uses the VITA token as a governance token that lets holders vote on proposals and decide which longevity research projects get funding. This helps the community guide the direction of the research and development efforts.

Research and Development

VitaDAO funds early-stage scientific research focused on extending healthy human lifespans and developing new therapeutics for age-related diseases. It supports projects like Matrix Bio and VITA-FAST, which work on anti-aging compounds and drug candidates.

Intellectual Property Management

VitaDAO manages intellectual property (IP) related to longevity research. Token holders vote on how to license and use this IP, helping to ensure transparency and community control over important scientific discoveries.

Community and Collaboration

VitaDAO creates a collaborative ecosystem where scientists, researchers, and enthusiasts can work together. It uses decentralized tools and subDAOs to streamline decision-making and encourage active participation in advancing longevity science.

Innovation and Technology

The organization leverages blockchain and AI to accelerate scientific ideas and improve funding transparency. It also uses platforms like Molecule to tokenize IP, making it easier to finance and govern research rights.

Advantages

• VitaDAO funds early-stage longevity research that might not get support elsewhere, helping advance science in aging and lifespan extension.
• It uses a decentralized governance model where VITA token holders vote on funding decisions, giving the community control over research directions.
• Intellectual property from funded projects is tokenized as IP-NFTs, allowing transparent management and potential revenue sharing.
• The platform offers fast transaction speeds, low fees, and privacy features like zero-knowledge proofs and multi-signature wallets.
• VitaDAO enables anyone with internet access to participate in funding and decision-making, democratizing longevity research.
• It has a diverse portfolio of funded projects, which can reduce risk and increase chances of breakthroughs.

Disadvantages

• The price of VitaDAO tokens has shown significant volatility and decline, with a recent drop of around 9-10% in a week and a large retreat from its all-time high.
• As an early-stage and high-risk project, there is uncertainty about future price trends and project outcomes.
• Participation requires holding VITA tokens and an Ethereum wallet, which may be a barrier for some users.
• The decentralized autonomous organization (DAO) model depends on active community involvement, which can be challenging to maintain.
• Regulatory issues around crypto tokens may affect the project, though VitaDAO is aware of securities laws and takes a conservative approach.

Founders of VitaDAO

• Tyler Golato is the main founder of VitaDAO. He is also the founder of Molecule, another company related to decentralized science and intellectual property in biotech.
• Laurence Ion is a founding member of VitaDAO. He is a longevity advocate, investor, and entrepreneur who supports a community-driven approach to aging research.
• Paul Kohlhaas is mentioned as a co-founder of Molecule and a co-initiator involved with VitaDAO.
• Dr. Morten Scheibye-Knudsen is a key advisor and scientific founder behind VitaDAO’s first research project, contributing his expertise in longevity science.

These individuals helped start VitaDAO, which is a decentralized organization focused on funding and advancing early-stage longevity research.

Major Investors in VitaDAO

• Pharmaceutical and Venture Firms: Pfizer Ventures is a key investor, leading a $4.1 million funding round. Other notable venture funds include Shine Capital and L1 Digital.
• Prominent Individuals: Balaji Srinivasan, former CTO of Coinbase and a16z partner, and Ethereum co-founder Vitalik Buterin have invested in VitaDAO.
• Decentralized Science and Crypto Groups: BeakerDAO, Spaceship DAO, and other decentralized science organizations have participated in funding rounds.
• Additional Investors: Tioga Capital Partners, Double Peak Group, Joe Betts-Lacroix (Retro Biosciences), 1517 Fund (Thiel Fellowship founders), Emerging Longevity Ventures, Healthspan Capital, and several longevity-focused angel investors and biotech experts.

These investors support VitaDAO’s mission to fund and advance longevity research through a community-governed platform.

Halal Status of VitaDAO

No. There is no specific information or certification indicating that VitaDAO is halal. The available data does not confirm that VitaDAO meets Islamic finance or halal investment criteria.